Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript May 8, 2023

Syndax Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.59, expectations were $-0.6.

Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.

Sharon Klahre: Thank you, operator. Welcome,...